FMR1 GENE POLYMORPHISM IN POLYCYSTIC OVARY SYNDROME
- Авторлар: Tabeeva G.I1, Nemova Y.I1, Naidukova A.A1, Kuznetsova E.B2, Zaletaev D.B2, Chernukha G.E1
-
Мекемелер:
- Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- I.M. Sechenov First Moscow State Medical University
- Шығарылым: № 3 (2016)
- Беттер: 50-57
- Бөлім: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247648
- ID: 247648
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
Авторлар туралы
G. Tabeeva
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: bambine@mail.ru
MD, PhD, researcher at the Department of Gynecological Endocrinology Moscow 117997, Ac. Oparina str. 4, Russia
Yu. Nemova
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: j_nemova@hoonail.com
graduate student of department of gynecological endocrinology Moscow 117997, Ac. Oparina str. 4, Russia
A. Naidukova
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: aleeshla@mail.ru
post-graduate department of gynecological endocrinology Moscow 117997, Ac. Oparina str. 4, Russia
E. Kuznetsova
I.M. Sechenov First Moscow State Medical University
Email: kuznetsova.k@bk.ru
Ph.D., Leading Researcher, Laboratory of Human Molecular Genetics Moscow 119048, Trubetskaya str. 8, bid. 2, Russia
D. Zaletaev
I.M. Sechenov First Moscow State Medical UniversityPh.D., Professor, Head of Laboratory of Human Molecular Genetics Moscow 119048, Trubetskaya str. 8, bid. 2, Russia
G. Chernukha
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of RussiaMD, Professor, Head of the Department of Gynecological Endocrinology Moscow 117997, Ac. Oparina str. 4, Russia
Әдебиет тізімі
- Fauser В.C., Tarlatzis В.С., Rebar R.W., Legro R.S., Balen A.H., Lobo R. et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil. Steril. 2012; 97(1): 28-38. e25.
- Legro R.S., Modi B.P., Strauss J.F., McAllister J.M., 3rd. Functional genomics of PCOS: from GWAS to molecular mechanisms. Trends Endocrinol. Metab. 2015; 26(3): 118-24. doi: 10.1016/j.tem.2014.12.004.
- Gleicher N., Weghofer A., Barad D.H. Effects of race/ethnicity on triple CGG counts on FMR1 gene in infertile women and egg donors. Reprod. Biomed. Online. 2010; 20(4): 485-91.
- Hoffman G.E., Le W.W., Entezam A., Otsuka N., Tong Z.B., Nelson L. et al. Ovarian abnormalities in a mouse model of fragile X primary ovarian insufficiency. J. Histochem. Cytochem. 2012; 60(6): 439-56.
- Lu C., Lin L., Tan H., Wu H., Sherman S.L., Gao F. et al. Fragile X permutation RNA is sufficient to cause primary ovarian insufficiency in mice. Hum. Mol. Genet. 2012; 21(23): 5039-47.
- Conway G.S. Premature ovarian failure and FMR1 gene mutations: an update. Ann. Endocrinol. (Paris). 2010; 71(3): 215-7.
- Gleicher N., Weghofer A., Lee I.H., Barad D.H. FMR1 genotype with autoimmunity-associated polycystic ovary-like phenotype and decreased pregnancy chance. PLoS One. 2010; 5(12): ЄІ5303.
- Barad D.H., Weghofer A., Goyal A., Gleicher N. Further refinement in defining the effect of heterozygous-abnormal egg counts on the FMR1 (Fragile X) gene: definition of a distinct subgroup of PCOS patient, based on norma/low genotype. Fertil. Steril. 2009; 92(3, Suppl.): S105.
- Rotterdam ESHRE/ASMR-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term healthy risks related to polycystic ovary syndrome. Fertil. Steril. 2004; 81(1): 19-26.
- Shamilova N.N., Marchenko L.A., Dolgushina N. V., ZaletaevD. V., Sukhikh G. T The role of genetic and autoimmune factors in premature ovarian failure. J. Assist. Reprod. Genet. 2013; 30(5): 617-22.
- Gleicher N., Weghover A., Oktay K., Barad D.H. Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: a new infertility test? Acta Obstet. Gynecol. Scand. 2009; 88(9): 1024-30.
- Spath M.A., Feuch T.B., Allen E.G., SmitsA.P., YntemaH.G., van Kessei A.G. et al. Intra-indinidual stability over time of standardardized anti- Mullerian hormone in FMR1 premutation carries. Hum. Reprod. 2011; 26(8): 2185- 91.
- Choe S.A., Кіт K.C., Lee J.Y., Кіт C.H., Hwang D., Jee B.C. The relation between the number of CGG repeats and serum level of anti-Mullerian hormone in women without FMR1 premutation. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013; 169(2): 275-8.
- DeGeyter C., M’Rabet N., DeGeyter J., Ziircher S., Moffat R., Bosch N. et al. Similar prevalence of expanded CGG repeat length sinthe fragile X mental retardation I gene among infertile women and among women with provenfertility: a prospective study. Genet. Med. 2014; 16(5): 374-8.
- Kline J., Kinney A., Kelly A., Reuss M.L., Levin B. Predictors of antral follicle count during the reproductive years. Hum. Reprod. 2005; 20(8): 2179-89.
- Rohr J., Allen E.G., Charen K., Giles J., He W., Dominguez C. et al. Anti- Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study. Hum. Reprod. 2008; 23: 1220-5.
- Pastore L.M., Young S.L., Baker V.L., Karns L.B., Williams C.D., Silverman L.M. Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserve. Reprod. Sci. 2012; 19(11): 1226-31.
- Gleicher N., Weghofer A., Barad D.H. Ovarian reserve determinations suggest new function of FMR1 (fragile X) gene in regulating ovarian aging. Reprod. Biomed. Online. 2010; 20(6): 768-75.
- Gleicher N., Kushnir V.A., Weghofer A., Barad D.H. How the FMR1 gene became relevant to female fertility and reproductive medicine. Front. Genet. 2014; 5: 284.
- Ванян З.Э. Клинико-диагностическое значение аутоиммунных и генетических факторов при “бедном” овариальном ответе на стимуляцию суперовуляции в программах вспомогательных репродуктивных технологий: автореф. дисс.. канд. мед. наук. М.; 2015. 27с.